Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sangamo Therapeutics (SGMO) Change in Taxes (2024)

Sangamo Therapeutics has reported Change in Taxes over the past 1 years, most recently at $39000.0 for Q4 2024.

  • Quarterly results put Change in Taxes at $39000.0 for Q4 2024, changed N/A from a year ago — trailing twelve months through Sep 2025 was $39000.0 (changed N/A YoY), and the annual figure for FY2024 was -$556000.0, down 114.9%.
  • Change in Taxes for Q4 2024 was $39000.0 at Sangamo Therapeutics, down from $537000.0 in the prior quarter.
  • Over the last five years, Change in Taxes for SGMO hit a ceiling of $1.4 million in Q1 2024 and a floor of -$2.5 million in Q2 2024.